Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Repro Med Systems Inc

Healthcare US KRMD

3.93USD
-0.21(5.07%)

Last update at 2026-06-05T20:00:00Z

Day Range

3.914.21
LowHigh

52 Week Range

1.984.29
LowHigh

Fundamentals

  • Previous Close 4.14
  • Market Cap97.02M
  • Volume58551
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-8.28587M
  • Revenue TTM29.32M
  • Revenue Per Share TTM0.64
  • Gross Profit TTM 15.37M
  • Diluted EPS TTM-0.28

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -9.77358M -10.67516M -6.36444M -1.19426M 0.70M
Minority interest - - - - -
Net income -13.74106M -8.66114M -4.56282M -1.21206M 0.56M
Selling general administrative 20.37M 20.61M 17.86M 12.03M 9.77M
Selling and marketing expenses - - - - -
Gross profit 15.84M 15.37M 13.77M 14.94M 14.85M
Reconciled depreciation 0.87M 0.59M 0.46M 0.42M 0.34M
Ebit -10.26998M -10.74100M -7.00164M 3.62M 7.39M
Ebitda -9.39959M -10.15386M -6.53851M 4.04M 7.73M
Depreciation and amortization 0.87M 0.59M 0.46M 0.42M 0.34M
Non operating income net other - 0.11M 0.67M 0.06M -
Operating income -10.26998M -10.78087M -7.02954M -1.25479M 0.59M
Other operating expenses 38.79M 38.68M 30.52M 22.98M 19.16M
Interest expense - 0.15M 0.64M 4.82M 6.69M
Tax provision 3.97M -2.01402M -1.80162M 0.02M 0.13M
Interest income 0.56M 0.15M 0.01M 0.04M 0.08M
Net interest income 0.56M 0.15M 0.01M 0.04M 0.08M
Extraordinary items - - - - -
Non recurring - - - 2.45M -
Other items - - - - -
Income tax expense 3.97M -2.01402M -1.80162M 0.02M 0.13M
Total revenue 28.52M 27.90M 23.49M 24.18M 23.16M
Total operating expenses 26.11M 26.15M 20.80M 13.74M 10.85M
Cost of revenue 12.68M 12.53M 9.72M 9.24M 8.31M
Total other income expense net 0.50M -0.03987M 0.65M -2.42909M -3.38561M
Discontinued operations - - - - -
Net income from continuing ops -13.74106M -8.66114M 4.56M -1.21206M 0.56M
Net income applicable to common shares - -8.66114M -4.56282M -1.21206M 0.56M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 28.46M 42.33M 41.29M 39.92M 13.88M
Intangible assets 0.75M 0.79M 0.81M 0.84M 0.81M
Earning assets - - - - -
Other current assets 1.22M 1.46M 1.57M 0.81M 0.39M
Total liab 8.11M 11.01M 4.79M 3.76M 2.65M
Total stockholder equity 20.35M 31.33M 36.50M 36.16M 11.24M
Deferred long term liab - - - - -
Other current liab 2.69M -0.27780M 2.87M 2.90M 1.69M
Common stock 0.49M 0.49M 0.48M 0.47M 0.42M
Capital stock 0.49M 0.49M 0.48M 0.47M 0.42M
Retained earnings -23.31227M -9.57121M -0.91007M 3.65M 4.86M
Other liab - - - - -
Good will - - - - -
Other assets - 4.07M 1.96M 0.38M 0.21M
Cash 11.48M 17.41M 25.33M 27.32M 5.87M
Cash and equivalents - - - - -
Total current liabilities 4.45M 6.96M 4.79M 3.67M 2.41M
Current deferred revenue - 3.97M 0.09M 0.13M -
Net debt -7.03712M -12.48325M -24.73075M -27.07579M -5.48925M
Short term debt 0.79M 0.88M 0.60M 0.14M 0.14M
Short long term debt 0.31M 0.43M 0.51M - -
Short long term debt total 4.45M 4.93M 0.60M 0.24M 0.38M
Other stockholder equity 43.18M 40.41M 36.93M 32.04M 5.95M
Property plant equipment - 3.89M 1.20M 1.40M 0.99M
Total current assets 20.26M 29.80M 37.32M 37.53M 11.88M
Long term investments - - - - -
Net tangible assets - 30.54M 35.69M 35.31M 10.43M
Short term investments - - - - -
Net receivables 4.07M 4.53M 4.31M 2.57M 3.23M
Long term debt - - - - -
Inventory 3.48M 6.40M 6.11M 6.83M 2.39M
Accounts payable 0.98M 2.39M 1.23M 0.62M 0.57M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - - - -1.81924M
Additional paid in capital - - - - -
Common stock total equity - 0.49M 0.48M 0.47M 0.42M
Preferred stock total equity - - - - -
Retained earnings total equity - -9.57121M -0.91007M 3.65M -
Treasury stock - -3.84356M -3.84356M -3.84356M -0.34420M
Accumulated amortization - - - - -
Non currrent assets other 0.10M 0.10M 0.02M 0.02M 0.02M
Deferred long term asset charges - - - - -
Non current assets total 8.21M 12.53M 3.97M 2.39M 2.00M
Capital lease obligations 4.13M 4.49M 0.10M 0.24M 0.38M
Long term debt total - - - - 0.00265M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -2.80157M -0.36617M -1.03615M 1.31M -1.72982M
Change to liabilities 1.89M 0.69M 0.05M 0.12M -0.00090M
Total cashflows from investing activities -2.80157M -0.36617M -1.03615M 1.31M -1.72982M
Net borrowings -0.12714M 0.51M -0.00530M -0.00478M -0.00478M
Total cash from financing activities 0.28M 2.71M 23.22M 0.50M 0.01M
Change to operating activities 0.50M -1.50650M 0.99M 0.24M 0.05M
Net income -8.66114M -4.56282M -1.21206M 0.56M 0.91M
Change in cash -7.92663M -1.98040M 21.44M 2.13M -0.23573M
Begin period cash flow 25.33M 27.32M 5.87M 3.74M 3.97M
End period cash flow 17.41M 25.33M 27.32M 5.87M 3.74M
Total cash from operating activities -5.40455M -4.31951M -0.74332M 0.32M 1.48M
Issuance of capital stock 0.41M 2.20M 26.73M 0.51M 0.05M
Depreciation 0.59M 0.46M 0.42M 0.34M 0.31M
Other cashflows from investing activities -0.04051M -0.36617M -0.11555M 1.74M -1.50000M
Dividends paid - - - -0.18477M -
Change to inventory -0.29853M 0.72M -4.44130M -0.28460M -0.44520M
Change to account receivables 0.03M -1.01993M 0.67M -1.80381M 0.48M
Sale purchase of stock 0.41M 0.00000M -3.49936M -0.00282M -0.03682M
Other cashflows from financing activities 0.78M 0.92M 4.98M 0.18M -1.72982M
Change to netincome 1.05M 0.89M 2.98M 0.96M 0.28M
Capital expenditures 2.80M 0.38M 1.06M 0.43M 0.48M
Change receivables -0.22017M 1.02M 0.67M - -
Cash flows other operating 0.24M 0.76M 0.86M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -7.92663M -1.98040M 21.44M - -
Change in working capital 1.40M -1.11038M -2.93381M -1.54558M -0.01613M
Stock based compensation 3.08M 2.71M 1.62M 1.20M 0.37M
Other non cash items 0.21M -0.00101M 1.30M -0.05645M -0.06698M
Free cash flow -8.20612M -4.69474M -1.80448M -0.10492M 1.00M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
KRMD
Repro Med Systems Inc		 -0.21 5.07% 3.93 - 188.68 3.40 4.76 3.15 -9.5573
ISRG
Intuitive Surgical Inc		 3.24 0.77% 422.06 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 -5.1675 2.52% 200.15 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -3.16 3.08% 99.50 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 1.60 1.07% 151.16 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Repro Med Systems Inc

100 Corporate Drive, Mahwah, NJ, United States, 07430

Key Executives

Name Title Year Born
Ms. Linda M. Tharby Pres, CEO & Director 1968
Mr. Tom Adams Interim Chief Financial Officer NA
Mr. Christopher Pazdan Sr. VP of Operations NA
Mr. Brian Case Chief Technology Officer NA
Mr. Rob Cannon VP of Sales NA
Mr. Josh Bennett VP of Strategy & Bus. Devel. NA
Ms. Linda M. Tharby President, CEO & Director 1968
Mr. Thomas Adams CFO, Secretary & Treasurer 1973
Mr. Brian Case Chief Technology Officer 1973
Mr. Kenneth Miller Chief Commercial Officer 1969

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.